Review





Similar Products

hvegf  (R&D Systems)
96
R&D Systems hvegf
(A-C) Proliferation assays of primary LSECs treated with increasing doses <t>of</t> <t>hLIF</t> (A), hOSM (B) or hCT-1 (C). 100 ng/mL hLIF was used as positive control. (D) Proliferation assays of LSECs isolated from lifrΔEC mice treated with increasing doses of hLIF. (E&F) Proliferation assays of LSECs isolated from lifr f/f (E) or lifrΔEC (F) mice treated with increasing doses of <t>hVEGF.</t> (G&H) Western blot analysis of primary LSECs treated with hVEGF (G) or hLIF (H) (I) Western blot of primary hepatocytes treated with hLIF. (J) Proliferation assays of primary hepatocytes treated with increasing doses of hLIF. (K) Proliferation assays of AML12 cells treated with increasing doses of hLIF. (L) Immunofluorescence staining of AML12 cells treated with 80 ng/mL hHGF or hLIF. DAPI (blue), Ki67 (green). Scale bar: 50 μm.
Hvegf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hvegf-165/Recombinant+Human+VEGF+165+Protein/bio_rxiv__64898__2026__02__24__707802-241-7-8
Average 96 stars, based on 1 article reviews
hvegf - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
hvegf 165  (Cell Signaling Technology Inc)
90
Cell Signaling Technology Inc hvegf 165
(A-C) Proliferation assays of primary LSECs treated with increasing doses <t>of</t> <t>hLIF</t> (A), hOSM (B) or hCT-1 (C). 100 ng/mL hLIF was used as positive control. (D) Proliferation assays of LSECs isolated from lifrΔEC mice treated with increasing doses of hLIF. (E&F) Proliferation assays of LSECs isolated from lifr f/f (E) or lifrΔEC (F) mice treated with increasing doses of <t>hVEGF.</t> (G&H) Western blot analysis of primary LSECs treated with hVEGF (G) or hLIF (H) (I) Western blot of primary hepatocytes treated with hLIF. (J) Proliferation assays of primary hepatocytes treated with increasing doses of hLIF. (K) Proliferation assays of AML12 cells treated with increasing doses of hLIF. (L) Immunofluorescence staining of AML12 cells treated with 80 ng/mL hHGF or hLIF. DAPI (blue), Ki67 (green). Scale bar: 50 μm.
Hvegf 165, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hvegf-165/vegf+165/pmc10758102-205-0-2
Average 90 stars, based on 1 article reviews
hvegf 165 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
human vascular endothelial growth factor hvegf  (R&D Systems)
97
R&D Systems human vascular endothelial growth factor hvegf
(A-C) Proliferation assays of primary LSECs treated with increasing doses <t>of</t> <t>hLIF</t> (A), hOSM (B) or hCT-1 (C). 100 ng/mL hLIF was used as positive control. (D) Proliferation assays of LSECs isolated from lifrΔEC mice treated with increasing doses of hLIF. (E&F) Proliferation assays of LSECs isolated from lifr f/f (E) or lifrΔEC (F) mice treated with increasing doses of <t>hVEGF.</t> (G&H) Western blot analysis of primary LSECs treated with hVEGF (G) or hLIF (H) (I) Western blot of primary hepatocytes treated with hLIF. (J) Proliferation assays of primary hepatocytes treated with increasing doses of hLIF. (K) Proliferation assays of AML12 cells treated with increasing doses of hLIF. (L) Immunofluorescence staining of AML12 cells treated with 80 ng/mL hHGF or hLIF. DAPI (blue), Ki67 (green). Scale bar: 50 μm.
Human Vascular Endothelial Growth Factor Hvegf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hvegf-165/Recombinant+Human+VEGF+165+Protein/pm37045813-572-31-39
Average 97 stars, based on 1 article reviews
human vascular endothelial growth factor hvegf - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier
recombinant hvegf 165  (Fisher Scientific)
90
Fisher Scientific recombinant hvegf 165
(A-C) Proliferation assays of primary LSECs treated with increasing doses <t>of</t> <t>hLIF</t> (A), hOSM (B) or hCT-1 (C). 100 ng/mL hLIF was used as positive control. (D) Proliferation assays of LSECs isolated from lifrΔEC mice treated with increasing doses of hLIF. (E&F) Proliferation assays of LSECs isolated from lifr f/f (E) or lifrΔEC (F) mice treated with increasing doses of <t>hVEGF.</t> (G&H) Western blot analysis of primary LSECs treated with hVEGF (G) or hLIF (H) (I) Western blot of primary hepatocytes treated with hLIF. (J) Proliferation assays of primary hepatocytes treated with increasing doses of hLIF. (K) Proliferation assays of AML12 cells treated with increasing doses of hLIF. (L) Immunofluorescence staining of AML12 cells treated with 80 ng/mL hHGF or hLIF. DAPI (blue), Ki67 (green). Scale bar: 50 μm.
Recombinant Hvegf 165, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hvegf-165/recombinant+human+vegf/pm35365614-247-18-23
Average 90 stars, based on 1 article reviews
recombinant hvegf 165 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
hvegf 165 quantikine elisa human vegf immunoassay kit  (R&D Systems)
96
R&D Systems hvegf 165 quantikine elisa human vegf immunoassay kit
(A-C) Proliferation assays of primary LSECs treated with increasing doses <t>of</t> <t>hLIF</t> (A), hOSM (B) or hCT-1 (C). 100 ng/mL hLIF was used as positive control. (D) Proliferation assays of LSECs isolated from lifrΔEC mice treated with increasing doses of hLIF. (E&F) Proliferation assays of LSECs isolated from lifr f/f (E) or lifrΔEC (F) mice treated with increasing doses of <t>hVEGF.</t> (G&H) Western blot analysis of primary LSECs treated with hVEGF (G) or hLIF (H) (I) Western blot of primary hepatocytes treated with hLIF. (J) Proliferation assays of primary hepatocytes treated with increasing doses of hLIF. (K) Proliferation assays of AML12 cells treated with increasing doses of hLIF. (L) Immunofluorescence staining of AML12 cells treated with 80 ng/mL hHGF or hLIF. DAPI (blue), Ki67 (green). Scale bar: 50 μm.
Hvegf 165 Quantikine Elisa Human Vegf Immunoassay Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hvegf-165/Human+VEGF+Quantikine+ELISA+Kit/us11254738-861-17-24
Average 96 stars, based on 1 article reviews
hvegf 165 quantikine elisa human vegf immunoassay kit - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
hvegf 165  (Meso Scale Diagnostics LLC)
90
Meso Scale Diagnostics LLC hvegf 165
Structural and affinity data for VEGF ligands for which a co-structure with the growth factor has been published.
Hvegf 165, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hvegf-165/hvegf+165/pmc08625919-7-19-58
Average 90 stars, based on 1 article reviews
hvegf 165 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
hvegf  (R&D Systems Hematology)
96
R&D Systems Hematology hvegf
Structural and affinity data for VEGF ligands for which a co-structure with the growth factor has been published.
Hvegf, supplied by R&D Systems Hematology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hvegf-165/Recombinant+Human+VEGF+165+Protein/us11124769-1169-23-24
Average 96 stars, based on 1 article reviews
hvegf - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

Image Search Results


(A-C) Proliferation assays of primary LSECs treated with increasing doses of hLIF (A), hOSM (B) or hCT-1 (C). 100 ng/mL hLIF was used as positive control. (D) Proliferation assays of LSECs isolated from lifrΔEC mice treated with increasing doses of hLIF. (E&F) Proliferation assays of LSECs isolated from lifr f/f (E) or lifrΔEC (F) mice treated with increasing doses of hVEGF. (G&H) Western blot analysis of primary LSECs treated with hVEGF (G) or hLIF (H) (I) Western blot of primary hepatocytes treated with hLIF. (J) Proliferation assays of primary hepatocytes treated with increasing doses of hLIF. (K) Proliferation assays of AML12 cells treated with increasing doses of hLIF. (L) Immunofluorescence staining of AML12 cells treated with 80 ng/mL hHGF or hLIF. DAPI (blue), Ki67 (green). Scale bar: 50 μm.

Journal: bioRxiv

Article Title: The LIF-LIFR Axis Promotes Liver Regeneration via Modulation of Angiogenesis and HGF Release from LSECs

doi: 10.64898/2026.02.24.707802

Figure Lengend Snippet: (A-C) Proliferation assays of primary LSECs treated with increasing doses of hLIF (A), hOSM (B) or hCT-1 (C). 100 ng/mL hLIF was used as positive control. (D) Proliferation assays of LSECs isolated from lifrΔEC mice treated with increasing doses of hLIF. (E&F) Proliferation assays of LSECs isolated from lifr f/f (E) or lifrΔEC (F) mice treated with increasing doses of hVEGF. (G&H) Western blot analysis of primary LSECs treated with hVEGF (G) or hLIF (H) (I) Western blot of primary hepatocytes treated with hLIF. (J) Proliferation assays of primary hepatocytes treated with increasing doses of hLIF. (K) Proliferation assays of AML12 cells treated with increasing doses of hLIF. (L) Immunofluorescence staining of AML12 cells treated with 80 ng/mL hHGF or hLIF. DAPI (blue), Ki67 (green). Scale bar: 50 μm.

Article Snippet: The proteins which included hLIF (Abcam, #ab287941), hVEGF (R&D system, #293-VE), hOSM (R&D system, #8475-OM), hCT1 (R&D system, 612-CD-010), IL-6 (PeproTech, 200-06), hHGF(R&D system, 294-HG), mHGF (R&D system, 2207-HG-025), EGF (R&D system, 236-EG), aLIF (UCSD), MAb mouse IgG2a isotype control (BioXcell,C1.18.4, #BE0085), anti-VEGF antibody B20-4.1.1 (Genentech) were added to cells at various concentrations, as indicated in the figures.

Techniques: Positive Control, Isolation, Western Blot, Immunofluorescence, Staining

Structural and affinity data for VEGF ligands for which a co-structure with the growth factor has been published.

Journal: Molecules

Article Title: A Structural Overview of Vascular Endothelial Growth Factors Pharmacological Ligands: From Macromolecules to Designed Peptidomimetics

doi: 10.3390/molecules26226759

Figure Lengend Snippet: Structural and affinity data for VEGF ligands for which a co-structure with the growth factor has been published.

Article Snippet: , Dual dAb , Similar to VEGFR-1 D2 , Mammalian cell-derived hVEGF 165 : K d = 3.27 pM; E. coli expressed hVEGF 165 : K d = 3.14 pM/T200 SPR hVEGF-A 165 : EC 50 = 32 ± 2.7 pM; hVEGF 121: EC 50 = 127 ± 22.1 pM; mVEGF 164: EC 50 = 36 ± 4.7 pM/Mesoscale discovery binding assay VEGFR-1 IC 50 = 59 ± 11.8 pM;VEGFR-2 IC 50 = 22 ± 2.7 pM/receptor binding assay by Mesoscale discovery , V K ·dAb: 5FV1 V H dAb: 5FV2 [ ] .

Techniques: Competitive Binding Assay, Binding Assay, Enzyme-linked Immunosorbent Assay, Labeling, Mutagenesis, Thermal Shift Assay